πŸ‡ΊπŸ‡Έ FDA
Patent

US 8563573

Azaindole derivatives as CFTR modulators

granted A61KA61K31/437A61K45/06

Quick answer

US patent 8563573 (Azaindole derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/437, A61K45/06, A61P, A61P11/00